James J. O'Leary, Chief Medical Officer at Fusion Pharmaceuticals Inc. (FUSN), bought 300 shares at $17.00 ($5K) on 2020-06-30, disclosed to the SEC on 2020-07-02.
Open-market purchase of $5k FUSN by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| IMGN | SELL | 2013-04-12 | $540K | — | Filing → |
| IMGN | SELL | 2013-03-12 | $214K | — | Filing → |
| IMGN | SELL | 2013-03-08 | $27K | — | Filing → |